Patients regained movement in the experimental phase of polylaminin, capable of regenerating the spinal cord in people who suffered organ rupture
Disclaimer: The article linked is from a single source with a single perspective. Make sure to cross-check information against multiple sources to get a comprehensive view on the situation.
That’s right. You cut funding to the public research institutions that make these discoveries in the first place. That’ll show ‘em.